Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The parathyroid polyhormone hypothesis revisited.

E F Nemeth1

  • 1NPS Pharmaceuticals, Toronto, Ontario, Canada. enemeth@npsp.com

Kidney International. Supplement
|July 1, 2006
PubMed
Summary

The parathyroid hormone (PTH) C-terminal fragments show biological activity, particularly in secondary hyperparathyroidism. These fragments inhibit bone resorption, impacting calcium homeostasis in specific conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures.

Calcified tissue international·2015
Same author

Allosteric modulators of the extracellular calcium receptor.

Drug discovery today. Technologies·2013
Same author

Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis.

Kidney international·2007
Same author

Misconceptions about calcimimetics.

Annals of the New York Academy of Sciences·2006
Same author

Summary--calcium receptors: potential targets for novel treatments for skeletal disease.

Journal of musculoskeletal & neuronal interactions·2005
Same author

Calcimimetic and calcilytic drugs: just for parathyroid cells?

Cell calcium·2004

Area of Science:

  • Endocrinology
  • Bone Biology
  • Hormone Physiology

Background:

  • The parathyroid polyhormone hypothesis suggests C-terminal fragments of parathyroid hormone (PTH) are biologically active.
  • Evidence for C-terminal fragment bioactivity and a novel receptor remains inconclusive.
  • In vivo pharmacology studies are crucial for assessing physiological significance.

Purpose of the Study:

  • To evaluate the physiological relevance of C-terminal PTH fragments using in vivo pharmacology data.
  • To investigate the role of C-terminal fragments in calcium homeostasis and bone resorption.

Main Methods:

  • Focus on in vivo pharmacology studies.
  • Analysis of circulating levels of C-terminal fragments and PTH.
  • Assessment of hypocalcemic effects and bone resorption inhibition.

Main Results:

  • Compelling evidence suggests C-terminal fragment bioactivity is physiologically relevant in secondary hyperparathyroidism.
  • Circulating C-terminal fragments significantly exceed PTH levels in this condition.
  • C-terminal fragments exhibit a hypocalcemic effect via direct inhibition of bone resorption.

Conclusions:

  • C-terminal fragments of PTH are physiologically relevant in secondary hyperparathyroidism.
  • These fragments directly inhibit bone resorption, contributing to hypocalcemia.
  • A role in normal calcium homeostasis remains less clear based on current in vivo data.

Related Experiment Videos